小型试验，需要巨大的需求。
In rare disease research, unmet patient needs are spurring new scientific discoveries. But with small, hard-to-find patient populations, each study requires an experienced team who knows how to navigate the nuances. And tackle the unknowns. So you can bring new treatments to patients and their families.
Rise to the challenge
您的工作给有7,000种罕见疾病之一的人口超过3.5亿人带来了希望。有了很少的批准治疗，您可以真正改变。
但是，您在寻找分散的患者，确定有意义的终点，创建新颖的研究设计并完美地执行所有内容时面临巨大的挑战。
Backed by the exceptional approach and resources of IQVIA, the leading Human Data Science Company™, our unified team of experts is ready to help.
针对稀有疾病量身定制的分散试验
336研究
自2016年以来，全球71个国家的稀有疾病Access the latest in human science and data science to accelerate results
IQVIA puts unparalleled data, actionable insights, advanced technology, and deep therapeutic expertise to work in solutions that will accelerate results for rare diseases. By tapping into these integrated capabilities, you can
- 确定正确的站点：通过IQVIA的专有算法和IQVIA的稀有疾病专家分析的现实世界数据，识别治疗患者为您的方案处理患者的网站
- 全球和广阔的范围：利用伊克维亚广泛的全球网站和稀有疾病的患者倡导小组关系
- Collaborate with experts:受益于去过那里并分娩的稀有疾病专家；我们的专家可以提供有关从复杂研究和协议设计到监管部门批准和报销市场的顾问
- 改善商业决定：IQVIA's advanced analytics, including machine learning and predictive analytics capabilities, help you generate new insights from your data
- 请参阅新的创新和治疗的影响：在计划和执行再生药物以及细胞和基因疗法方面保持领先地位
通过将数据，专业知识，分析和技术从研究设计到执行到更好的决策来改变临床研究模型。
从候选人识别到市场授权，访问高级治疗开发的新资源。
更丰富的现实世界数据见解可以推动更明智的决定。betway必威怎么提款